Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
59,119,327
-
Total 13F shares
-
54,287,178
-
Share change
-
+1,414,775
-
Total reported value
-
$764,978,865
-
Put/Call ratio
-
136%
-
Price per share
-
$14.09
-
Number of holders
-
158
-
Value change
-
+$13,754,283
-
Number of buys
-
83
-
Number of sells
-
85
Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock (VNDA) as of Q2 2019
As of 30 Jun 2019,
Vanda Pharmaceuticals Inc. - Common Stock (VNDA) was held by
158 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,287,178 shares.
The largest 10 holders included
BlackRock Inc., Palo Alto Investors LP, Consonance Capital Management LP, VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, MACQUARIE GROUP LTD, Invesco Ltd., and Stonepine Capital Management, LLC.
This page lists
158
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.